Differential Sensitivity to Escherichia coli Infection in Mice Lacking Tumor Necrosis Factor p55 or Interleukin-1 p80 Receptors
- 1 November 1996
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Surgery
- Vol. 131 (11) , 1216-1221
- https://doi.org/10.1001/archsurg.1996.01430230098017
Abstract
Objective: To determine the effect of targeted disruption of the cellular receptors of either tumor necrosis factor α (TNF-α) or interleukin-1β (IL-1β) during experimental gram-negative bacterial infection and endotoxemia. Design: Transgenic (knockout [KO]) mice deficient in either the p55 TNF receptor (TNF RI) or the p80 IL-1 receptor (IL-1 RI) were challenged with intravenous lipopolysaccharide (endotoxin) or intraperitoneal liveEscherichia coli0111:B4. Mortality was assessed daily for 7 days. Serum endotoxin levels and quantitative blood cultures were monitored at multiple times during infection. Setting: Surgical infectious disease research laboratory. Main Outcome Measures: Mortality, results of quantitative blood cultures, and serum endotoxin levels. Results: Both TNF and IL-1 RI KO mice were resistant to endotoxin challenge (0% mortality for both groups) compared with control mice (100% mortality [P<.01]). In contrast, only the IL-1 RI KO mice were resistant to infection caused by viable gram-negative bacteria (43% mortality) compared with control mice (100% mortality [P<.01]). Infection led to 100% mortality in TNF RI KO mice. The IL-1 RI KO mice exhibited less bacteremia and diminished endotoxemia compared with control and TNF RI KO mice 18 and 24 hours after infection. Conclusion: The absence of either the TNF or the IL-1 RI receptor prevents cellular activation by each respective cytokine. Absence confers protection against intravenous endotoxin, which stimulates massive rapid release of cytokines into the systemic circulation. However, bacterial infection within the peritoneal cavity is known to cause more delayed cytokine release, and cytokines may act at the site of infection to enhance host defenses. We believe that IL-1 signaling may be more critical in provoking lethal systemic toxic effects than TNF signaling. However, TNF signaling may be an important component of host defense enhancement at the local site of infection. Arch Surg. 1996;131:1216-1221Keywords
This publication has 14 references indexed in Scilit:
- Immunological Screening and Immunotherapy in Critically ill Patients with Abdominal InfectionsPublished by Springer Nature ,2001
- Inhibition of Splenic Macrophage Tumor Necrosis Factor α Secretion In Vivo by Antilipopolysaccharide Monoclonal AntibodiesArchives of Surgery, 1994
- Cytokine Mediators of Immunity and InflammationArchives of Surgery, 1993
- Shock and Multiple-Organ Dysfunction after Self-Administration of Salmonella EndotoxinNew England Journal of Medicine, 1993
- Targeted homologous recombination in mammalian cellsCritical Reviews in Oncology/Hematology, 1992
- A tumor necrosis factor (TNF) receptor-IgG heavy chain chimeric protein as a bivalent antagonist of TNF activity.The Journal of Experimental Medicine, 1991
- Role of Endotoxin and Host Cytokines in Septic ShockChest, 1991
- Interleukin 1: the first interleukinImmunology Today, 1990
- Tumor necrosis factor in the pathophysiology of infection and sepsisClinical Immunology and Immunopathology, 1990
- Establishment in culture of pluripotential cells from mouse embryosNature, 1981